The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Histone H3 globular domain acetylation identifies a new class of enhancers
Open accessAbstract
Histone acetylation is generally associated with active chromatin, but most studies have focused on the acetylation of histone tails. Various histone H3 and H4 tail acetylations mark the promoters of active genes. These modifications include acetylation of histone H3 at lysine 27 (H3K27ac), which blocks Polycomb-mediated trimethylation of H3K27 (H3K27me3). H3K27ac is also widely used to identify active enhancers, and the assumption has been that profiling H3K27ac is a comprehensive way of cataloguing the set of active enhancers in mammalian cell types. Here we show that acetylation of lysine residues in the globular domain of histone H3 (lysine 64 (H3K64ac) and lysine 122 (H3K122ac)) marks active gene promoters and also a subset of active enhancers. Moreover, we find a new class of active functional enhancers that is marked by H3K122ac but lacks H3K27ac. This work suggests that, to identify enhancers, a more comprehensive analysis of histone acetylation is required than has previously been considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, enhancers devoid of the classic H3K27ac mark have recently been described [163]; consistent with this, it was shown that this mark is not required for enhancer function, at least in mouse ESCs [164].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
GREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016071107 · Cited by 4,302
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–241 of 241
Li, L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727748600.793554891
Regulatory de novo mutations underlying intellectual disabilityPreprint
Vas, M. G. D., Boulet, F., Joshi, S. S., Garstang, M. G., Khan, T. N., Atla, G., Parry, D., Moore, D., Cebola, I., Zhang, S., et al. (2022) · medRxiv · doi:10.1101/2022.11.14.22279410
Self-citationAI-driven designed protein epigenomics
Levy, S., & Ruohola‐Baker, H. (2023) · Clinical Research in Oncology · doi:10.46439/oncology.1.01
Non-coding mutations at enhancer clusters contribute to pancreatic ductal adenocarcinomaPreprint
Wang, J., Patel, M. B., Maniati, E., Atanur, S. S., Pal, D., Rio‐Machín, A., Heward, J. A., Kocher, H. M., Fitzgibbon, J., & Pradeepa, M. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3120592/v1
Self-citationEpigenetic Control of Cell Fate Decisions by Enhancer-Derived Long Noncoding RNAs
Mattick, J. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-59286-7_2
Epigenetics and Chromatin Remodeling
Kinyamu, H. K., Theofilatos, D., Mackey, L. C., & Archer, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00260-6
Epigenetics changes during allergen immunotherapy – Review of available literature
Carewicz, A., Michalska-Radź, O. A., Tomasiak, M. M., Moniuszko, M., Eljaszewicz, A., & Carewicz, P. (2025) · Gene · doi:10.1016/j.gene.2025.149535
Non-canonical enhancers control gene expression and cell fate in human pluripotent stem cellsPreprint
Cao, Y., Dovgusha, O., Ebrahımı, A., Bevan, S., Widmer, L., Torabi, F., Kurlovich, J., Rodríguez-Polo, I., Khan, S., Patel, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.01.657118
“In mouse ESCs, non-canonical enhancers have been identified that lack H3K27ac but instead are enriched for acetylation in the histone H3 core domain 29 .”
InfluentialSelf-citationFrost, S., Fernández‐Aroca, D. M., Parey, E., Rodriguez-Gonzalez, A., Pavon-Heredia, D., & Villar, D. (2026) · Heart · doi:10.1136/heartjnl-2026-bcs.327
An epigenomic investigation of atrial fibrillation in a matched left and right atrial human cohortPreprint
Rodríguez-González, A., Frost, S., Thomas, A., Fernández‐Aroca, D. M., Choudhury, J., Tikkas, G., Tinker, A., Munroe, P. B., Bell, C. G., & Villar, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.29.673028
Chromatin landscape and enhancer-gene interaction differences between three cardiac cell typesPreprint
Zhu, Y., Grenier, J., Poujol, R., Koslowski, S., Tastet, O., Lee, C. J. M., Ackers-Johnson, M. A., Foo, R., Hussin, J., & Anene-Nzelu, C. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.23.678180
“A well-known example of histone acetylation is H3K27ac (acetylation of lysine 27 of the H3 histone subunit) 18 , and it is one of the most studied active enhancer markers 19–21 .”
Kumar, Y., Sengupta, D., Friman, E. T., Illingworth, R. S., Soleil, M., Fan, Z., Wang, H., Helin, K., Gérard, M., & Bickmore, W. A. (2025) · eLife · doi:10.7554/elife.108802.1
Self-citationAdditional file 4 of CREaTor: zero-shot cis-regulatory pattern modeling with attention mechanisms
Li, Y., Ju, F., Chen, Z., Qu, Y., Xia, H., He, L., Wu, L., Zhu, J., Shao, B., & Deng, P. (2024) · Figshare · doi:10.6084/m9.figshare.26644375
Additional file 2 of CREaTor: zero-shot cis-regulatory pattern modeling with attention mechanisms
Li, Y., Ju, F., Chen, Z., Qu, Y., Xia, H., He, L., Wu, L., Zhu, J., Shao, B., & Deng, P. (2024) · Figshare · doi:10.6084/m9.figshare.24630433
Additional file 1 of CREaTor: zero-shot cis-regulatory pattern modeling with attention mechanisms
Li, Y., Ju, F., Chen, Z., Qu, Y., Xia, H., He, L., Wu, L., Zhu, J., Shao, B., & Deng, P. (2023) · Figshare · doi:10.6084/m9.figshare.24630349
Wolfe, J. C., Mikheeva, L. A., Hagras, H., & Zabet, N. R. (2021) · Figshare · doi:10.6084/m9.figshare.16960406
Wolfe, J. C., Mikheeva, L. A., Hagras, H., & Zabet, N. R. (2021) · Figshare · doi:10.6084/m9.figshare.16960409
Lindhorst, D., & Halfon, M. S. (2023) · Figshare · doi:10.6084/m9.figshare.22607942
Additional file 3 of CREaTor: zero-shot cis-regulatory pattern modeling with attention mechanisms
Li, Y., Ju, F., Chen, Z., Qu, Y., Xia, H., He, L., Wu, L., Zhu, J., Shao, B., & Deng, P. (2024) · Figshare · doi:10.6084/m9.figshare.26644372
BRD4 represses developmental and neuronal genes through interaction with PRC1.6Preprint
Boulet, F., Patel, M., Zanjani, Z. S., Andrés-Sánchez, N., Ijaz, A., Pal, D., Dubey, P., Murray, A., Nižetić, D., LeClaire, M. D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.31.702994
“6-regulated genes following BRD4 depletion, and associated changes in PRC1.”
Kumar, Y., Sengupta, D., Friman, E. T., Illingworth, R. S., Soleil, M., Fan, Z., Wang, H., Helin, K., Gérard, M., & Bickmore, W. A. (2026) · eLife · doi:10.7554/elife.108802.2
Self-citationLiu, M., Jin, K., Qi, S., Chen, D., Han, Y., Xu, W., Wen, C., Wen, H., Liu, Y., He, B. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.17.712507
An epigenomic investigation of atrial fibrillation in a matched left and right atrial human cohort
Rodriguez, A., Frost, S., Thomas, A., Fernández‐Aroca, D. M., Choudhury, J., Tikkas, G., Tinker, A., Munroe, P. B., Bell, C. G., & Villar, D. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02076-2
“Albeit H3K27ac is known to be dysregulated across a range of cardiovascular diseases [43, 44, 81], epigenomic regions defined by other histone modifications, such as those associated to non-canonical enhancers [82], are also likely to be modified in permanent AF.”
Benaissa, M. (2018) · theses.fr (ABES) · doi:10.70675/19229be6zcf7cz4317z80f0ze5bd9b22c989
Computational analysis and modelling of regulatory networks controlling embryonic development
Floc’hlay, S. (2020) · theses.fr (ABES) · doi:10.70675/8d0e3a18z3294z4502z870dz9c18564e6415
Étude de l’impact mutationnel d’une perte de méthylation de l’ADN chez Arabidopsis thaliana
Baillet, V. (2018) · theses.fr (ABES) · doi:10.70675/2967bc12zaa3ez4d05zbf40z16688b339e1d
Tools to analyze single-particle tracking data in mammalian cells
Woringer, M. (2019) · theses.fr (ABES) · doi:10.70675/bf8f07fdzcbc2z44f3z96bcz2a51c16db330
Oishi, T., Hatazawa, S., Kujirai, T., Suzuki, S., Nakatsu, K., Hayashi, G., Kato, J., Kobayashi, Y., Ogasawara, M., Ehara, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.02.722397
“Moreover, H3K64ac is known to co-localize with transcriptionally active histone marks, including H3K27ac, H3K4me1, and H3K122ac, suggesting that H3K64ac may regulate transcription through crosstalk with other PTMs (13, 23).”
Explainable AI identifies H3K18ac as a new marker of active enhancersPreprint
Maqsood, K., Brandao, D. P., Wolfe, J., Kayyar, B., Clinciu, C. G., Bosnea, R. A., Grant, O. A., Boulet, F., Bell, C. G., Ficz, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731088 · Cited by 1
“ChIP-STARR-seq focussed on sequences most likely to be enhancers (ChIP of several histone modifications associated with enhancers and several TFs specific to hESC), but it might miss potential enhancers enriched in other histone modifications 12,13,76 .”
Self-citationBhagat, P. P., Sharma, T. G., Shirasath, K. R., Goyal, S. N., & Awathale, S. N. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.06.033
Transcriptional perturbation of LINE-1 elements reveals their cis-regulatory potential
Perez-Rico, Y. A., Breton, A. L., Bousard, A., Misikova, L. H., Mulugeta, E., de Almeida, S. F., Muotri, A. R., Heard, É., & Gendrel, A.-V. (2026) · EMBO Reports · doi:10.1038/s44319-026-00854-w · Cited by 4
“Interestingly, the 5 ’ UTR regions of some active young L1 elements are enriched with H4K16ac and H3K122ac, chromatin features associated with active enhancers in human ESCs (Pal et al, 2023; Pradeepa et al, 2016; Taylor et al, 2013).”
Oishi, T., Hatazawa, S., Kujirai, T., Suzuki, S., Nakatsu, K., Hayashi, G., Kato, J., Kobayashi, Y., Ogasawara, M., Ehara, H., et al. (2026) · eLife · doi:10.7554/elife.111802
Oishi, T., Hatazawa, S., Kujirai, T., Suzuki, S., Nakatsu, K., Hayashi, G., Kato, J., Kobayashi, Y., Ogasawara, M., Ehara, H., et al. (2026) · eLife · doi:10.7554/elife.111802.1
Wei, Q., & Dong, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34069-7.00008-2
Unlocking cis -regulatory landscapes across 500 million years of evolution and disease mechanisms
Gonçalves, T. M., Stewart, C. L., Baxley, S. D., Xu, J., Boyer, K., George, B., Li, D., Yang, C., Gabel, H. W., Piao, X., et al. (2026) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqag107
ELF5‐Mediated Enhancer–Promoter Interaction Regulates LALBA Expression in Ovine Mammary Gland
Wu, X., Wang, J., Hao, Z., Li, M., Zhen, H., Liu, Y., Zhao, G., ren, C., Zhou, X., Hu, H., et al. (2026) · Advanced Science · doi:10.1002/advs.78138
Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
Ren, Y., Yang, L., Fei, B., Guo, R., Huang, J., Xu, Z., Wang, R., Zhang, P., Cao, D., Chen, P., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3356-1
Heady, L., Fenelon, K. D., Delint‐Ramírez, I., Rueda, R., Segev, A., Morton, K. G., Briseno, S. F., & Madabhushi, R. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118186
Metadata
- Authors
- Pradeepa, M. M., Grimes, G. R., Kumar, Y., Olley, G., Taylor, G. C. A., Schneider, R., & Bickmore, W. A.
- Affiliations
- University of Essex (GB)
- Institute of Genetics and Cancer (GB)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Pradeepa, Madapura M
- Bickmore, Wendy A
- ORCID
- Venue
- Nature Genetics
- Published
- 2016-04-18
- Volume
- 48
- Issue
- 6
- Pages
- 681-686
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4886833
- OpenAlex
- W2342153705
- Cited by
- 240
- References
- 47
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 18 · 2023: 22 · 2022: 22 · 2021: 24 · 2020: 36 · 2019: 27 · 2018: 21 · 2017: 21 · 2016: 7
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Open Access at Essex (University of Essex) (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Medical Research Council
- FP7 Ideas: European Research Council (249956)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- histone acetylation, H3K27ac, enhancers, promoter, chromatin modification, embryonic stem cells, cancer cell lines, enhancer identification
- MeSH terms
- Acetylation, Enhancer Elements, Genetic, Gene Expression Regulation, Histones, Humans, Lysine, K562 Cells, Chromatin Immunoprecipitation, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
